Literature DB >> 8053697

The significance of eccentric foci of hyperpigmentation ('small dark dots') within melanocytic nevi. Analysis of 59 cases.

J L Bolognia1, A Lin, P E Shapiro.   

Abstract

BACKGROUND AND
DESIGN: Fifty-nine melanocytic nevi with eccentric foci of hyperpigmentation ("small dark dots") that measured primarily 1 to 2 mm in diameter were prospectively examined to determine the histologic correlates of the dark dots.
RESULTS: Forty-one (69%) of the dark dots were due to increased melanin in epidermal melanocytes and/or keratinocytes, usually accompanied by melanophages; of these 41, six (15%) were associated with slight or moderate melanocytic nuclear atypia. Fifteen (25%) of the dark dots were due to increased dermal pigment that was either superficial or deep. Three (5%) of the dark dots were due to melanoma arising within a nevus.
CONCLUSIONS: A small percentage of "small dark dots" within melanocytic nevi are due to melanoma. Biopsy specimens of nevi with small dark dots should be sectioned to ensure histologic examination of this focus of hyperpigmentation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8053697

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  3 in total

Review 1.  Strategies for early melanoma detection: Approaches to the patient with nevi.

Authors:  Agnessa Gadeliya Goodson; Douglas Grossman
Journal:  J Am Acad Dermatol       Date:  2009-05       Impact factor: 11.527

2.  Evolving clonal nevus-case report with serial digital dermatoscopy and dermatopathology.

Authors:  Mike Inskip; Jill Magee
Journal:  Dermatol Pract Concept       Date:  2015-01-30

3.  Differential rates of replacement of human dermal dendritic cells and macrophages during hematopoietic stem cell transplantation.

Authors:  Muzlifah Haniffa; Florent Ginhoux; Xiao-Nong Wang; Venetia Bigley; Michal Abel; Ian Dimmick; Sarah Bullock; Marcos Grisotto; Trevor Booth; Peter Taub; Catharien Hilkens; Miriam Merad; Matthew Collin
Journal:  J Exp Med       Date:  2009-01-26       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.